Other Clinical Trial - Exploratory Study of MT-8554 in Subjects With

Updated 06/21/2024

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate the efficacy, safety, tolerability and pharmacokinetics of MT-8554, compared to placebo, in subjects with painful diabetic peripheral neuropathy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Diabetic Neuropathies
Pain
Painful Diabetic Peripheral Neuropathy
Peripheral Nervous System Diseases

Clinical Trial Details

NCT number	NCT05123196
Study type	Interventional
Source	Mitsubishi Tanabe Pharma Corporation
Contact
Status	Completed
Phase	Phase 2
Start date	November 16, 2021
Completion date	November 8, 2022

See also
	Status	Clinical Trial	Phase
	Not yet recruiting	`NCT06158529` - High-frequency Electrical Spinal Cord Stimulation Versus Electrical Spinal Cord Stimulation in the Treatment of Diabetic Peripheral Neuropathic Pain	N/A
	Completed	`NCT01726413` - A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients).	Phase 2
	Terminated	`NCT04246619` - Efficacy of Pregabalin and Duloxetine in Patients With PDPN: the Effect of Pain on Cognitive Function, Sleep and Quality of Life	Phase 4
	Recruiting	`NCT03520608` - Painful Diabetic Peripheral Neuropathy Study of Chinese OutPatiEnt
	Completed	`NCT03172598` - Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy	Phase 2
	Terminated	`NCT01280747` - Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study
	Completed	`NCT03176472` - Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy	Phase 2
	Completed	`NCT01455415` - Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain	Phase 3